Arcellx, Inc. (ACLX)
66.07
+0.56
(+0.85%)
USD |
NASDAQ |
Dec 24, 12:59
66.05
-0.02
(-0.03%)
After-Hours: 13:59
Arcellx SG&A Expense (TTM): 110.28M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.886B |
| Johnson & Johnson | 23.38B |
| Bristol Myers Squibb Co. | 7.222B |
| Geron Corp. | 160.96M |
| Regeneron Pharmaceuticals, Inc. | 2.717B |